Cellectis
CLLS
#7640
Rank
C$0.54 B
Marketcap
C$5.39
Share price
-3.69%
Change (1 day)
149.16%
Change (1 year)

Cellectis (CLLS) Fails to deliver data

Key failure to deliver metrics for Cellectis:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Cellectis (CLLS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Cellectis (CLLS) - since 2015

Volume in USD (price x number of shares), data since 2015

Cellectis (CLLS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026C$0.16 M-53.86%
2025C$0.36 M-59.6%
2024C$0.9 M-64.26%
2023C$2.53 M-35.43%
2022C$3.92 M-74.81%
2021C$15.59 M-26.71%
2020C$21.27 M2750.05%
2019C$0.74 M-93.48%
2018C$11.44 M85.32%
2017C$6.17 M-25.24%
2016C$8.26 M-76.95%
2015C$35.83 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Regeneron Pharmaceuticals
REGN
C$3.27 MC$44.45 M๐Ÿ‡บ๐Ÿ‡ธ USA
uniQure
QURE
C$5.52 MC$39.65 M๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
C$5.09 MC$61.25 M๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
C$0.51 MC$4.8 M๐Ÿ‡บ๐Ÿ‡ธ USA